Therapeutic Asset Ratings

13,155 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Ipilimumab Bladder Transitional Cell Carcinoma	M.D. Anderson Cancer Center	P2	B (59)
Ipilimumab Castration-Resistant Prostate Carcinoma	Exelixis	P2	B (59)
Ipilimumab Gastrointestinal Stromal Tumor	National Cancer Institute (NCI)	P2	B (59)
Ipilimumab Neuroendocrine Carcinoma	National Cancer Institute (NCI)	P2	B (59)
Ipilimumab HIV Infectious Disease	Universita di Verona	P2	B (59)
Ipilimumab Intrahepatic Cholangiocarcinoma	TriSalus Life Sciences, Inc.	P2	B (59)
Ipilimumab Plasmacytoid Variant Infiltrating Bladder Urothelial Carcinoma	National Cancer Institute (NCI)	P2	B (59)
Ipilimumab Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant	National Cancer Institute (NCI)	P2	B (59)
Ipilimumab Kidney Medullary Carcinoma	National Cancer Institute (NCI)	P2	B (59)
Ipilimumab Rectum Adenocarcinoma	National Cancer Institute (NCI)	P2	B (59)
Ipilimumab Renal Pelvis Urothelial Carcinoma	M.D. Anderson Cancer Center	P2	B (59)
Ipilimumab Ureter Transitional Cell Carcinoma	M.D. Anderson Cancer Center	P2	B (59)
Ipilimumab Urethra Transitional Cell Carcinoma	M.D. Anderson Cancer Center	P2	B (59)
Ipilimumab Peritoneal Mesothelioma	TCR2 Therapeutics	P2	B (59)
Ipilimumab Penile Carcinoma	National Cancer Institute (NCI)	P2	B (59)
Ipilimumab Ovarian Germ Cell Tumor	National Cancer Institute (NCI)	P2	B (59)
Ipilimumab Squamous Cell Carcinoma Of Penis	National Cancer Institute (NCI)	P2	B (59)
Ipilimumab Urinary Bladder Cancer	M.D. Anderson Cancer Center	P2	B (59)
Ipilimumab Ureter Cancer	M.D. Anderson Cancer Center	P2	B (59)
Ipilimumab Urethra Cancer	M.D. Anderson Cancer Center	P2	B (59)
Isocyclophosphamide Follicular Lymphoma	David Bond, MD	P2	B (59)
Jcar-017 Cd19-Specific Chimeric Antigen Receptor High Grade B-Cell Lymphoma	Fred Hutchinson Cancer Center	P2	B (59)
Kras Tcr-Transduced Pbl Metastatic Malignant Neoplasm	National Cancer Institute (NCI)	P2	B (59)
Ladiratuzumab Vedotin HER2 Positive Breast Carcinoma	Seagen Inc.	P2	B (59)
Lapatinib Neoplasm	Deraya University	P2	B (59)

Showing 2351 to 2375 of 13,155 assets

PreviousPage 95 of 527Next